about
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection.[Confusional syndrome in a patient with severe hyponatremia][Meropenem and valproic acid: A clinically relevant drug-drug interaction]
P50
description
researcher ORCID ID = 0000-0003-0544-4690
@en
wetenschapper
@nl
name
Guillermo Ojeda-Burgos
@ast
Guillermo Ojeda-Burgos
@en
Guillermo Ojeda-Burgos
@es
Guillermo Ojeda-Burgos
@nl
type
label
Guillermo Ojeda-Burgos
@ast
Guillermo Ojeda-Burgos
@en
Guillermo Ojeda-Burgos
@es
Guillermo Ojeda-Burgos
@nl
prefLabel
Guillermo Ojeda-Burgos
@ast
Guillermo Ojeda-Burgos
@en
Guillermo Ojeda-Burgos
@es
Guillermo Ojeda-Burgos
@nl
P106
P1153
51562265800
P21
P31
P496
0000-0003-0544-4690